Mechanistic studies show that NSUN2 regulates the m5C modification of QSOX1, and YBX1 enhances QSOX1 translation in an m5C-dependent manner, thereby promoting resistance to EGFR-mutant lung cancer (2). The gene discussed is YBX1; the disease is lung carcinoma.